Mallinckrodt Pharmaceuticals Drug For Further Processing
NDC Database

Mallinckrodt Pharmaceuticals Drug For Further Processing

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 21
  • Latest Marketing Date 2022-12-19
  • Data Source FDA
  • First Marketing Date 1982-12-20
All
102
View
Bulk Ingredient
81
View
Drug for Further Processing
21
View
Company Overview

Company

Mallinckrodt Pharmaceuticals Drug For Further Processing

Country

Ireland

Website

Visit Website

Email

simon.plevin@mnk.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Mallinckrodt Pharmaceuticals Drug For Further Processing

College Business & Technology Park Cruiserath, Blanchardstown Dublin 15

Ireland

www.mallinckrodt.com/ simon.plevin@mnk.com View on Map
NDC Records ( 21 records )
1982
20 Dec
Drug for Further Processing NDC: 0406-0090

Nonproprietary Name

Acetaminophen Anhydrous Basis

Dosage Form

POWDER

Strength

0.9 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-0090

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1982-12-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

1982
20 Dec
Drug for Further Processing NDC: 0406-0093

Nonproprietary Name

Acetaminophen Anhydrous Basis

Dosage Form

POWDER

Strength

0.9 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-0093

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1982-12-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
08 Feb
Drug for Further Processing NDC: 0406-0114

Nonproprietary Name

ACETAMINOPHEN ANHYDROUS BASIS

Dosage Form

POWDER

Strength

0.9 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-0114

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-08

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
11 Feb
Drug for Further Processing NDC: 0406-0117

Nonproprietary Name

Acetaminophen Anhydrous Basis And Chlorpheniramine Maleate

Dosage Form

POWDER

Strength

.9; .0055 kg/kg; kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-0117

Substance

ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

1982
20 Dec
Drug for Further Processing NDC: 0406-0161

Nonproprietary Name

Acetaminophen Anhydrous Basis

Dosage Form

POWDER

Strength

0.9 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-0161

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1982-12-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
11 Feb
Drug for Further Processing NDC: 0406-0244

Nonproprietary Name

Acetaminophen Anhydrous Basis

Dosage Form

POWDER

Strength

0.9 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-0244

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

1982
20 Dec
Drug for Further Processing NDC: 0406-0960

Nonproprietary Name

Acetaminophen Anhydrous Basis

Dosage Form

POWDER

Strength

0.9 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-0960

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1982-12-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
19 Dec
Drug for Further Processing NDC: 0406-1123

Nonproprietary Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Dosage Form

TABLET

Strength

325; 5 mg/1; mg/1

Labeler

SpecGx LLC

Marketing Category

EXPORT ONLY

0406-1123

Substance

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

CII

Start Marketing Date

2022-12-19

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
19 Dec
Drug for Further Processing NDC: 0406-1124

Nonproprietary Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Dosage Form

TABLET

Strength

325; 7.5 mg/1; mg/1

Labeler

SpecGx LLC

Marketing Category

EXPORT ONLY

0406-1124

Substance

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

CII

Start Marketing Date

2022-12-19

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
19 Dec
Drug for Further Processing NDC: 0406-1125

Nonproprietary Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Dosage Form

TABLET

Strength

325; 10 mg/1; mg/1

Labeler

SpecGx LLC

Marketing Category

EXPORT ONLY

0406-1125

Substance

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

CII

Start Marketing Date

2022-12-19

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
29 Apr
Drug for Further Processing NDC: 0406-1593

Nonproprietary Name

diphenoxylate hydrochloride

Dosage Form

POWDER

Strength

.01; .99 kg/kg; kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-1593

Substance

ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

CV

Start Marketing Date

2013-04-29

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
13 Feb
Drug for Further Processing NDC: 0406-2907

Nonproprietary Name

acetaminophen anhydrous basis

Dosage Form

POWDER

Strength

0.95 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-2907

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-13

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
08 Feb
Drug for Further Processing NDC: 0406-3823

Nonproprietary Name

IBUPROFEN

Dosage Form

POWDER

Strength

0.63 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-3823

Substance

IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-08

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
08 Feb
Drug for Further Processing NDC: 0406-3825

Nonproprietary Name

Ibuprofen

Dosage Form

POWDER

Strength

0.9 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-3825

Substance

IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-08

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
11 Feb
Drug for Further Processing NDC: 0406-3930

Nonproprietary Name

Acetaminophen Anhydrous Basis / Paracetamol Ph Eur

Dosage Form

POWDER

Strength

0.97 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-3930

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
08 Feb
Drug for Further Processing NDC: 0406-3973

Nonproprietary Name

PARACETAMOL

Dosage Form

POWDER

Strength

0.96 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-3973

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-08

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
08 Feb
Drug for Further Processing NDC: 0406-3975

Nonproprietary Name

PARACETAMOL

Dosage Form

POWDER

Strength

0.96 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-3975

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-08

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
13 Feb
Drug for Further Processing NDC: 0406-4255

Nonproprietary Name

acetaminophen

Dosage Form

POWDER

Strength

0.95 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-4255

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-13

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
08 Feb
Drug for Further Processing NDC: 0406-4377

Nonproprietary Name

PARACETAMOL

Dosage Form

POWDER

Strength

0.955 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-4377

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-08

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
08 Feb
Drug for Further Processing NDC: 0406-6114

Nonproprietary Name

ACETAMINOPHEN ANHYDROUS BASIS

Dosage Form

POWDER

Strength

0.9 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-6114

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-02-08

End Marketing Date

-

Listing Record Certified Through

2026-12-31

1997
09 Sep
Drug for Further Processing NDC: 0406-7509

Nonproprietary Name

ACETAMINOPHEN ANHYDROUS BASIS

Dosage Form

POWDER

Strength

0.9 kg/kg

Labeler

SpecGx LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

0406-7509

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1997-09-09

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    27 View
  • EDQM CEP
    21 View
  • KDMF
    0 View
  • Japan DMF
    7 View
  • Eudra GMP
    0 View
  • NDC Database
    102 View
  • FDA Approved Drugs Database
    244 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
21 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

0406-0090

Nonproprietary Name

Acetaminophen Anhydrous Basis

Labeler

SpecGx LLC

Dosage Form

POWDER

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit